Navigation Links
D3 Launches New Suite of Solutions, including the First Radiation Oncology Clinical Pathways Program, at the ASTRO Annual Meeting, October 31 - November 3, 2010 in San Diego
Date:10/28/2010

PITTSBURGH, Oct. 28 /PRNewswire/ -- D3 Radiation Planning has a new name: D3 Radiation Oncology Solutions.  The company chose its new name to reflect the recent expansion in the number of new solutions that D3 offers to accelerate excellence in radiation oncology.

(Logo: http://photos.prnewswire.com/prnh/20101028/NE90717LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20101028/NE90717LOGO)

"The future of radiation oncology belongs to those practices that recognize and address changes and challenges in the field today," said Kathy Lokay, president and chief executive officer, D3 Radiation Oncology Solutions. "Continuing to build on our affiliation with UPMC and UPMC Cancer Centers, D3 has new solutions to help practices achieve and sustain excellence – in quality, safety, efficiency, and outcomes."

D3's new suite of solutions, which will be launched at the upcoming ASTRO Annual Meeting in San Diego, includes:

D3 Radiation Oncology Pathways: The first and only commercially available pathway solution for radiation oncology developed and maintained by a distinguished group of academic and community radiation oncologists.  D3 Radiation Oncology Pathways provide treatment recommendations for each unique patient presentation in a web-based interactive decision support tool. In an era of increased payer scrutiny over the appropriateness of utilization and costs of cancer care, D3 Radiation Oncology Pathways help practices prove their quality and avoid external administrative oversight.

D3 Quality Assurance and Peer Review Programs: These solutions support practices to ensure quality and patient safety, differentiate themselves in their market, and prepare to achieve American College of Radiology (ACR) or American College of Radiation Oncology (ACRO) accreditation.  

Flexible Options for Treatment Planning: D3 now offers practices with multiple locations and high patient volume assistance in establishing their own centralized treatment planning centers of excellence. D3 also continues to offer On-Demand Dosimetry to centers experiencing short- or long-term dosimetry staff vacancies. D3's expertise in treatment planning is unsurpassed. Since 2001, D3 has developed more than 20,000 treatment plans.

Clinical Training: D3's experienced, ABR board certified and clinically active medical physicists and dosimetrists work in collaboration with practices to accelerate and optimize the application of advanced technologies through hands-on operations and clinical training coupled with extensive post-training validation and peer review.

Commissioning: Whether fully outsourced or facilitated, D3's commissioning solutions are performed in a consultative manner with a rigorous methodology from acceptance testing and data collection to modeling and validation. And D3 now has experience commissioning Varian TrueBeam™.

"Our clinical staff has an average of 20 years of radiation oncology experience, and since 2001 we have supported more than 250 practices in the U.S. and internationally," said Greg Ross, chief operating officer, D3 Radiation Oncology Solutions. "With the D3 suite of solutions, we are applying our expertise and experience to help practices be successful as they face today's intensifying demands for quality, safety and efficiency."

D3 Radiation Oncology Solutions is exhibiting at the American Society for Radiation Oncology (ASTRO) Annual Meeting at the San Diego Convention Center, October 31 – November 3, 2010. D3 will be at booth #121. Reservations for scheduled demonstrations of D3 Radiation Oncology Pathways may be made by contacting Lindsey Briggs at (412) 365-0719.

D3 Radiation Oncology Solutions

D3 Radiation Oncology Solutions, Pittsburgh, Penn., has been a trusted source of technical expertise and industry knowledge in radiation oncology since 2001. D3 solutions have been developed with leading experts through its affiliation with UPMC and UPMC Cancer Centers. D3 offers the solutions practices need today for success tomorrow and delivers them with unmatched expertise proven over a decade. From flexible options for commissioning and treatment planning to pathways and other tools and programs that support clinical quality, D3 solutions accelerate excellence in radiation oncology. For more information, please access D3's website at www.d3rad.com or call (412) 365-0710.

TrueBeam™ is a trademark of Varian Medical Systems, Inc.


'/>"/>
SOURCE D3 Radiation Oncology Solutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Paragon Bioservices Launches Second Expansion to Celebrate its 20th Anniversary
2. Medco Launches Online Safety Net to Increase Adherence and Prevent Avoidable Medication Risks
3. Global Sources launches integrated, multi-channel offerings for three fast-growing export sectors
4. Sigma-Aldrich Launches Senior Notes Offering
5. Hospira Launches Piperacillin and Tazobactam for Injection in the United States
6. Diplomat Specialty Pharmacy Launches Diplomat University - Hires Jennifer Hagerman, PharmD, Pharmacy Professor
7. IDEV Technologies Launches Additional Products in Europe
8. C PORT Solutions Launches MEDI PORT to Bring Powerful New Telemedicine Solutions to the Hospital Bedside
9. Cipla Launches the Worlds First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis)
10. Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training
11. Brazoria County Launches Free Prescription Discount Card
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... December 9, 2016 External ... Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators ... Cardioverter Defibrillators The global defibrillators ... CAGR of 5.3% from 2016-2020 and CAGR of ... grow at a CAGR of 5.2% from 2016 ...
(Date:12/9/2016)... Research and Markets has announced the addition of the ... ... the global optical transceiver market to grow at a CAGR of ... the present scenario and the growth prospects of the global optical ... considers the revenue generated from the shipment of optical transceivers worldwide ...
(Date:12/9/2016)... 9, 2016 Mitsubishi Tanabe Pharma Corporation (Head ... Director, CEO: Dr. Masayuki Mitsuka ) has presented ... given edaravone intravenously in 10-14 day cycles for 48 ... the ALS Functional Rating Scale-Revised (ALSFRS-R). The data were ... ALS/MND in Dublin, Ireland . ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... 2016 , ... MEDI+SIGN®, a provider of fully-automated patient monitoring ... for Emergency Departments (ED) has been added to their portfolio. Housed in a ... and with a simplified pallet of information available to the patient, the Digital ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical Institute ... The name change aligns the entire company with its existing Quality Insights ... , “We are very proud of the achievements associated with the West Virginia ...
(Date:12/8/2016)... ... 08, 2016 , ... Russ DiGilio , founder and ... #QuackGivesBack campaign which supported local breast cancer organizations during National Breast Cancer Awareness ... Back initiative, and we’re very pleased with the participation in every franchisee’s ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... , ... December 08, 2016 , ... David J. ... global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, ... the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical Technology ...
Breaking Medicine News(10 mins):